With solutions intended to be progressively absorbed by the body over time, bioabsorbable implants are redefining the medical device industry. These implants are essential in many medical applications because they prevent the need for additional removal operations by offering temporary support while the body heals. The industry is rising as a result of continuing developments in material science, consumer demand for less intrusive procedures, and an ageing population with related health demands.
Novel bioabsorbable materials with better mechanical characteristics and increased biocompatibility are being developed as a result of ongoing advancements in material science. The use of bioabsorbable implants is becoming more widespread in a variety of medical professions because to this development. Globally, people’s choice for less intrusive surgical methods is driving the growth of bioabsorbable implants. For these treatments, bioabsorbable implants are especially well suited since they enable less invasiveness and quicker patient recovery.
From 2024 to 2034, the market for bioabsorbable implants is expected to grow globally at a CAGR of 2.3%.
It is estimated that bioabsorbable stent sales would reach US$ 180 million by 2024.
Advanced bioabsorbable implant sales are being driven by high healthcare costs and a supportive regulatory framework that encourages innovation in North America.
Robust healthcare infrastructure and a significant emphasis on research and development are driving market expansion in Europe.
Due to factors including a huge patient population, rising healthcare expenditures, and a growing demand for cutting-edge medical technology, the Asia Pacific market is expanding healthily.
In the US, chronic illnesses including cardiovascular disease and orthopaedic issues are becoming far more prevalent. Due to its novelty and promise to improve patient outcomes—particularly in orthopaedic and cardiovascular applications—bioabsorbable implants are growing in popularity.
In the US, bioabsorbable implants may benefit from a rather favourable regulatory environment with clear regulations and clearance procedures. This facilitates the introduction of novel bioabsorbable implants and technologies into the market, increasing sales of the corresponding goods.
With its latest product, Fact.MR offers a dispassionate evaluation of the worldwide bioabsorbable implant market, including demand data from 2018 to 2023 as well as projections for 2024 to 2034.
Across six major regions of the world (North America, Latin America, Europe, East Asia, South Asia & Oceania, and MEA), the study provides crucial insights into the market based on product type (stents, biological meshes, fixation devices, and others), material (metallic, ceramic, polymers, and others), application (orthopaedic, cardiovascular), and end user (hospitals, ambulatory surgical centres, specialty clinics).
MR is a prestigious market research firm well-known for its thorough market analyses and priceless business insights. Being a major force in business intelligence, we provide in-depth analysis that reveals competitive environments, development trajectories, and market trends. Prominent for its dedication to precision and dependability, we furnish enterprises with essential information and tactical suggestions, enabling well-informed decision-making and augmenting competitive stance. FACT.MR’s steadfast commitment to delivering trustworthy market intelligence enables businesses to confidently navigate ever-changing market obstacles and achieve sustained success. With a staff of knowledgeable analysts and a global reach, FACT.MR guarantees that its clients get insights that can be put to use in order to seize new possibilities and maintain an advantage over competitors.